XML 45 R36.htm IDEA: XBRL DOCUMENT v3.4.0.3
Fair Value of Financial Instruments - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 23, 2014
Jul. 01, 2013
Fair Value of Financial Instruments [Line Items]            
Cash and cash equivalents $ 27,653,000 $ 59,074,000 $ 120,844,000 $ 120,841,000    
Cash equivalents, money market funds 26,000,000 55,800,000        
Sanofi-Aventis Deutschland GmbH            
Fair Value of Financial Instruments [Line Items]            
Carrying value 63,500,000 44,500,000        
Estimated fair value 48,200,000 36,500,000        
Senior convertible notes due August 15, 2018            
Fair Value of Financial Instruments [Line Items]            
Carrying value 27,618,000 $ 27,613,000        
License and Collaboration Agreement with Sanofi            
Fair Value of Financial Instruments [Line Items]            
Maximum secured loan facility         $ 175,000,000  
License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH            
Fair Value of Financial Instruments [Line Items]            
Maximum secured loan facility 175,000,000          
Carrying value 63,500,000          
Estimated fair value 48,200,000          
Milestone Rights Liability | Deerfield | Maximum            
Fair Value of Financial Instruments [Line Items]            
Contingent liability for milestone payments           $ 90,000,000
Milestone Rights Liability | Senior convertible notes due December 31, 2019 | Deerfield            
Fair Value of Financial Instruments [Line Items]            
Long term liability 8,900,000         $ 13,100,000
Fair Value, Inputs, Level 3 | Milestone Rights Liability            
Fair Value of Financial Instruments [Line Items]            
Fair value of Milestone Rights $ 17,700,000          
Fair Value, Inputs, Level 3 | Income Approach Valuation Technique | Sanofi-Aventis Deutschland GmbH            
Fair Value of Financial Instruments [Line Items]            
Market discount rate 11.00%          
Fair Value, Inputs, Level 3 | Income Approach Valuation Technique | Senior convertible notes due December 31, 2019            
Fair Value of Financial Instruments [Line Items]            
Market discount rate 12.00%          
Fair Value, Inputs, Level 3 | Income Approach Valuation Technique | Milestone Rights Liability            
Fair Value of Financial Instruments [Line Items]            
Market discount rate 14.50%          
Fair Value, Inputs, Level 3 | Income Approach Valuation Technique | Less portion of commitment asset | Senior convertible notes due December 31, 2019            
Fair Value of Financial Instruments [Line Items]            
Market discount rate 11.00%          
Fair Value, Inputs, Level 3 | Market Approach Valuation Technique | Senior convertible notes due August 15, 2018 | Convertible Debt Securities            
Fair Value of Financial Instruments [Line Items]            
Fair value assumption, risk-free rate 21.00%          
Fair value assumption, stock price volatility 100.00%